A convertible bond of Lantheus Holdings, a diagnostic and radiopharmaceutical company that develops and commercializes imaging agents used in cardiovascular, oncology, and other medical procedures.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Howard Marks / Oaktree | 69 | Added +84% | 11,525,000 | $13,233,581 | 0.2% |
| Louis Bacon / Moore | 55 | Added +30% | 25,984 | $1,729,235 | 0.0% |
| Bridgewater | 49 | Trimmed -44% | 166,706 | $11,094,284 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.